457 related articles for article (PubMed ID: 33308241)
1. Plasma levels and tissue expression of soluble TGFβrIII receptor in women with early-stage breast cancer and in healthy women: a prospective observational study.
Grgurevic L; Novak R; Trkulja V; Hrkac S; Salai G; Bilandzic J; Hamzic LF; Milas I; Vucemilo T; Balja MP; Bilic K
J Transl Med; 2020 Dec; 18(1):478. PubMed ID: 33308241
[TBL] [Abstract][Full Text] [Related]
2. Soluble type III TGFβ receptor in diagnosis and follow-up of patients with breast cancer.
Jurisic D; Erjavec I; Trkulja V; Dumic-Cule I; Hadzibegovic I; Kovacevic L; Svagusa T; Stanec Z; Vukicevic S; Grgurevic L
Growth Factors; 2015; 33(3):200-9. PubMed ID: 26190421
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of soluble TGF ß receptor type III: no apparent promise as a marker in acute pancreatitis.
Salai G; Zelenika M; Hrkač S; Trkulja V; Bilandžić J; Grgurević I; Novak R; Grgurević L
Croat Med J; 2021 Jun; 62(3):264-269. PubMed ID: 34212563
[TBL] [Abstract][Full Text] [Related]
4. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Lin SY; Wang YY; Sheu WH
Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size.
Singer CF; Mogg M; Koestler W; Pacher M; Marton E; Kubista E; Schreiber M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4003-9. PubMed ID: 15217931
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.
Kong FM; Anscher MS; Murase T; Abbott BD; Iglehart JD; Jirtle RL
Ann Surg; 1995 Aug; 222(2):155-62. PubMed ID: 7543740
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.
Bae HJ; Eun JW; Noh JH; Kim JK; Jung KH; Xie HJ; Park WS; Lee JY; Nam SW
Oncol Rep; 2009 Sep; 22(3):475-80. PubMed ID: 19639191
[TBL] [Abstract][Full Text] [Related]
9. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.
Gobbi H; Arteaga CL; Jensen RA; Simpson JF; Dupont WD; Olson SJ; Schuyler PA; Plummer WD; Page DL
Histopathology; 2000 Feb; 36(2):168-77. PubMed ID: 10672063
[TBL] [Abstract][Full Text] [Related]
11. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
[TBL] [Abstract][Full Text] [Related]
12. Baseline staging imaging for distant metastasis in women with stages I, II, and III breast cancer.
Arnaout A; Varela NP; Allarakhia M; Grimard L; Hey A; Lau J; Thain L; Eisen A
Curr Oncol; 2020 Apr; 27(2):e123-e145. PubMed ID: 32489262
[TBL] [Abstract][Full Text] [Related]
13. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
Blackwell K; Haroon Z; Broadwater G; Berry D; Harris L; Iglehart JD; Dewhirst M; Greenberg C
J Clin Oncol; 2000 Feb; 18(3):600-8. PubMed ID: 10653875
[TBL] [Abstract][Full Text] [Related]
14. Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls.
Nariţa D; Seclaman E; Ursoniu S; Ilina R; Cireap N; Anghel A
Rom J Morphol Embryol; 2011; 52(4):1261-7. PubMed ID: 22203932
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of hepatocyte growth factor in patients with breast cancer.
Sheen-Chen SM; Liu YW; Eng HL; Chou FF
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
[TBL] [Abstract][Full Text] [Related]
16. Patients With Invasive Ductal Carcinoma Have Reduced Levels of Decorin Expression in Their Breast Tissue Compared to Patients With Fibroadenoma While Plasma Decorin Remains Unchanged.
Falakian Z; Shahani T; Rezaie R; Mazloomzadeh S; Sirati F; Jalilvand A; Jahangiri F; Bahmani P; Jadali F; Atarian S; Eghdam-Zamir R; Biglari A
Arch Iran Med; 2018 Nov; 21(11):509-517. PubMed ID: 30551691
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
Zhang G; Zhang W; Li B; Stringer-Reasor E; Chu C; Sun L; Bae S; Chen D; Wei S; Jiao K; Yang WH; Cui R; Liu R; Wang L
Breast Cancer Res; 2017 Jun; 19(1):73. PubMed ID: 28637482
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
20. Plasma transforming growth factor beta levels in breast cancer patients.
Sminia P; Barten AD; van Waarde MA; Vujaskovic Z; van Tienhoven G
Oncol Rep; 1998; 5(2):485-8. PubMed ID: 9468585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
